Delivery Order SPE2DB22D9353-SPE2DB25FX2EK
- Not listed
- The Defense Logistics Agency awarded a $36,976.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $36,976.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The contract, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The contract, which became effective on August 1, 2025, with an ultimate completion date of August 4, 2025, was issued without set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $55,464.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and does not utilize a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on June 6, 2025, with an ultimate completion date of June 9, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform this delivery order from its Park Ridge, Illinois...
- The Defense Logistics Agency awarded a $26,827.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $36,976.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its facility in Park Ridge. The contract carries an ultimate completion date of July 24, 2025, and no set-aside designation was utilized in this award. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $93,269.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count unit dosage). This firm fixed-price delivery order was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and does not utilize a set-aside designation. The contract falls under DMS Pharmaceutical Group's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $36,976.24 by the Defense Logistics Agency (DLA) on July 31, 2025, with an ultimate completion date of August 1, 2025. The delivery order, issued under a firm fixed-price contract structure with no set-aside designation, covers the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). Performance will occur at the contractor's...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $18,474.02 to DMS Pharmaceutical Group Inc. on August 12, 2025, for the supply of Trikafta 50-25-37.5 mg/75 mg tablets (84-count units). This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2EKDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $55,464.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price orders for pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts to deliver branded and generic prescription medications, biologics, and medical consumables to military health facilities. The company's contract portfolio demonstrates its capability to supply diverse pharmaceutical products ranging from specialty medications to over-the-counter items. Trikafta, a prescription medication used in the treatment of cystic fibrosis, represents the type of specialized pharmaceutical product within the vendor's distribution scope to federal healthcare systems. The firm fixed-price contract structure and rapid completion timeline reflect the delivery order mechanism's efficiency in fulfilling urgent pharmaceutical supply requirements through the established IDC vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.5k | 9/5/25 |